Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-23-002095

Chief Executive Officer acquired 26,668 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FRIEDMAN PAUL A Chief Executive Officer 2023-01-16 Grant or award +26,668 26,668 D
Loading xslF345X03/doc4.xml…